# Immuneering Corp: Form 8-K, filed Feb 2, 2024

- Company: [Immuneering Corp](/companies/imrx.md) (CIK 1790340)
- Form: 8-K
- Filed: 2024-02-02
- Accepted by EDGAR: Feb 2, 2024, 16:15 ET
- Period: 2024-02-01
- Accession: 0001104659-24-010041
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1790340/000110465924010041/tm245037d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1790340/000110465924010041/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1790340/000110465924010041/tm245037d1_8k.htm

Filed Feb 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-010041. Last ingested by Listed: Oct 29, 2026, 18:24 ET. No prices; not investment advice.